GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Cyclically Adjusted PB Ratio

Sci Pharmtech (TPE:4119) Cyclically Adjusted PB Ratio : 2.54 (As of Jun. 23, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Cyclically Adjusted PB Ratio?

As of today (2024-06-23), Sci Pharmtech's current share price is NT$90.30. Sci Pharmtech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was NT$35.62. Sci Pharmtech's Cyclically Adjusted PB Ratio for today is 2.54.

The historical rank and industry rank for Sci Pharmtech's Cyclically Adjusted PB Ratio or its related term are showing as below:

TPE:4119' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.18   Med: 2.64   Max: 4.22
Current: 2.54

During the past years, Sci Pharmtech's highest Cyclically Adjusted PB Ratio was 4.22. The lowest was 2.18. And the median was 2.64.

TPE:4119's Cyclically Adjusted PB Ratio is ranked worse than
60.82% of 753 companies
in the Drug Manufacturers industry
Industry Median: 1.87 vs TPE:4119: 2.54

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sci Pharmtech's adjusted book value per share data for the three months ended in Mar. 2024 was NT$43.025. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$35.62 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sci Pharmtech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sci Pharmtech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Cyclically Adjusted PB Ratio Chart

Sci Pharmtech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.23 2.37 2.53 2.65 2.79

Sci Pharmtech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.13 3.06 2.74 2.79 2.48

Competitive Comparison of Sci Pharmtech's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sci Pharmtech's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sci Pharmtech's Cyclically Adjusted PB Ratio falls into.



Sci Pharmtech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sci Pharmtech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=90.30/35.62
=2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sci Pharmtech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sci Pharmtech's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=43.025/131.7762*131.7762
=43.025

Current CPI (Mar. 2024) = 131.7762.

Sci Pharmtech Quarterly Data

Book Value per Share CPI Adj_Book
201406 21.993 100.560 28.820
201409 22.800 100.428 29.917
201412 23.308 99.070 31.003
201503 24.308 99.621 32.154
201506 24.286 100.684 31.786
201509 25.480 100.392 33.446
201512 26.427 99.792 34.897
201603 27.952 100.470 36.662
201606 26.958 101.688 34.934
201609 27.866 101.861 36.050
201612 28.174 101.863 36.448
201703 28.518 102.862 36.534
201706 25.957 103.349 33.097
201709 26.333 104.136 33.323
201712 26.879 104.011 34.054
201803 27.448 105.290 34.353
201806 27.245 106.317 33.769
201809 28.447 106.507 35.196
201812 29.452 105.998 36.615
201903 30.892 107.251 37.956
201906 29.296 108.070 35.723
201909 31.098 108.329 37.829
201912 31.878 108.420 38.745
202003 33.472 108.902 40.503
202006 31.559 108.767 38.235
202009 33.314 109.815 39.976
202012 30.480 109.897 36.548
202103 30.702 111.754 36.203
202106 30.643 114.631 35.226
202109 30.736 115.734 34.996
202112 30.465 117.630 34.129
202203 31.007 121.301 33.685
202206 32.220 125.017 33.962
202209 32.644 125.227 34.351
202212 33.296 125.222 35.039
202303 33.846 127.348 35.023
202306 37.700 128.729 38.593
202309 37.880 129.860 38.439
202312 42.674 129.419 43.451
202403 43.025 131.776 43.025

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sci Pharmtech  (TPE:4119) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sci Pharmtech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sci Pharmtech (TPE:4119) Business Description

Traded in Other Exchanges
N/A
Address
No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.

Sci Pharmtech (TPE:4119) Headlines

No Headlines